JP2016500250A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500250A5
JP2016500250A5 JP2015543148A JP2015543148A JP2016500250A5 JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5 JP 2015543148 A JP2015543148 A JP 2015543148A JP 2015543148 A JP2015543148 A JP 2015543148A JP 2016500250 A5 JP2016500250 A5 JP 2016500250A5
Authority
JP
Japan
Prior art keywords
amino acid
protein
modified protein
acid residues
reference secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015543148A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500250A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/071091 external-priority patent/WO2014081884A1/en
Publication of JP2016500250A publication Critical patent/JP2016500250A/ja
Publication of JP2016500250A5 publication Critical patent/JP2016500250A5/ja
Withdrawn legal-status Critical Current

Links

JP2015543148A 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法 Withdrawn JP2016500250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728427P 2012-11-20 2012-11-20
US61/728,427 2012-11-20
PCT/US2013/071091 WO2014081884A1 (en) 2012-11-20 2013-11-20 Engineered secreted proteins and methods

Publications (2)

Publication Number Publication Date
JP2016500250A JP2016500250A (ja) 2016-01-12
JP2016500250A5 true JP2016500250A5 (enExample) 2017-01-19

Family

ID=50776536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543148A Withdrawn JP2016500250A (ja) 2012-11-20 2013-11-20 改変された分泌タンパク質及び方法

Country Status (7)

Country Link
US (1) US20150307562A1 (enExample)
EP (1) EP2922416A4 (enExample)
JP (1) JP2016500250A (enExample)
CN (1) CN104936466A (enExample)
CA (1) CA2892021A1 (enExample)
HK (1) HK1214739A1 (enExample)
WO (1) WO2014081884A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10689681B2 (en) * 2013-05-31 2020-06-23 Dsm Ip Assets B.V. Microorganisms for diterpene production
BR112016002067A2 (pt) 2013-07-29 2017-08-29 Danisco Us Inc Variantes de enzimas
SG11201602012RA (en) * 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
GB201401699D0 (en) * 2014-01-31 2014-03-19 Dupont Nutrition Biosci Aps Protein
CN103881994B (zh) * 2014-04-14 2020-03-27 中国农业科学院生物技术研究所 一种具有高转糖苷活性的β-半乳糖苷酶突变体及其制备方法和应用
FR3022558B1 (fr) 2014-06-20 2019-01-25 Proteus Variants d'exoglucanases a activite amelioree et leurs utilisations
WO2016046234A2 (en) * 2014-09-22 2016-03-31 Nexttobe Ab Recombinant phe-free proteins for use in the treatment of phenylketonuria
WO2016054452A1 (en) * 2014-10-01 2016-04-07 Ansun Biopharma, Inc. Ecotin variants
WO2016077457A1 (en) * 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
MX383142B (es) 2014-12-19 2025-03-13 Novozymes As Composiciones que comprenden polipéptidos que tienen actividad xilanasa y polipéptidos que tienen actividad arabinofuranosidasa.
GB201501565D0 (en) * 2015-01-30 2015-03-18 Dupont Nutrition Biosci Aps Method
US20180243392A1 (en) * 2015-03-17 2018-08-30 Vanderbilt University Cs21 and lnga protein vaccines
AU2016282355B2 (en) * 2015-06-26 2020-04-09 Novozymes A/S Method for producing a coffee extract
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
JP7072151B2 (ja) * 2016-02-18 2022-05-20 天野エンザイム株式会社 腸内菌叢改善剤
ES3014057T3 (en) * 2016-05-24 2025-04-16 Novozymes As Gastric stable polypeptides having alpha-galactosidase activity and polynucleotides encoding same
AU2017270269A1 (en) * 2016-05-24 2018-11-15 Novozymes A/S Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity
AU2017269498A1 (en) 2016-05-24 2018-11-08 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
WO2018005035A1 (en) 2016-06-27 2018-01-04 Novozymes A/S Method of dewatering post fermentation fluids
RU2752204C2 (ru) * 2016-07-08 2021-07-23 Новозимс А/С Варианты ксиланазы и кодирующие их полинуклеотиды
WO2018016483A1 (ja) * 2016-07-19 2018-01-25 サントリーホールディングス株式会社 モグロールまたはモグロール配糖体の生産方法
MA43352B1 (fr) 2016-09-01 2019-08-30 Metax Inst Fuer Diaetetik Gmbh Protéine sans phénylalanine pour le traitement de la phénylcétonurie
EA201891926A1 (ru) * 2017-02-03 2019-04-30 Киверди, Инк. Микроорганизмы и искусственные экосистемы для производства белка, продуктов питания и полезных побочных продуктов из субстратов c1
CN110505903A (zh) * 2017-03-06 2019-11-26 杜邦营养生物科学有限公司 新型真菌岩藻糖苷酶及其在预防和/或治疗动物病原体感染中的用途
EP3840582A4 (en) * 2018-08-21 2022-08-03 Clara Foods Co. MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS
CA3118924A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
AR118444A1 (es) * 2019-03-19 2021-10-06 Bayer Cropscience Lp Proteínas de fusión, bacterias recombinantes y fragmentos de exosporas para la salud de las plantas
FI13395Y1 (fi) 2019-07-11 2023-06-06 Clara Foods Co Koostumuksia, jotka käsittävät rekombinanttia ovomukoidiproteiinia
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
EP4031661A1 (en) 2019-09-16 2022-07-27 Novozymes A/S Polypeptides having beta-glucanase activity and polynucleotides encoding same
EP3892290A1 (en) * 2020-04-08 2021-10-13 NUMAFERM GmbH Variants of hlya and uses thereof
WO2022194375A1 (en) 2020-03-18 2022-09-22 Numaferm Gmbh Fusion proteins comprising gg repeat sequences
WO2021207679A1 (en) * 2020-04-10 2021-10-14 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
KR20230107636A (ko) * 2020-11-13 2023-07-17 퍼펙트 데이, 인크. 식품 및 기타 제품에 사용하기 위한 재조합 성분을 생성하기 위한 방법 및 조성물
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CA3210777A1 (en) 2021-02-10 2022-08-18 Novozymes A/S Polypeptides having pectinase activity, polynucleotides encoding same, and uses thereof
EP4314242A4 (en) * 2021-03-25 2025-01-22 Bio-Cat, Inc. MIXTURES OF FUNGAL PROTEASES AND THEIR USES
CN114015678A (zh) * 2021-09-30 2022-02-08 中南民族大学 一种球形赖氨酸芽孢杆菌C3-41来源的氨肽酶Amp0279及其重组菌株和应用
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.
US20230281444A1 (en) * 2022-03-04 2023-09-07 Cella Farms Inc Computational system and algorithm for selecting nutritional microorganisms based on in silico protein quality determination
CA3253720A1 (en) 2022-04-20 2023-10-26 Novozymes A/S PROCESS FOR PRODUCING FREE FATTY ACIDS
US20250345378A1 (en) * 2022-05-04 2025-11-13 Locus Biosciences, Inc. Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof
CN115160420B (zh) * 2022-06-24 2023-06-02 西南大学 盔形毕赤酵母scp类分泌蛋白及其应用
WO2024220717A1 (en) * 2023-04-20 2024-10-24 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
WO2025155915A1 (en) * 2024-01-17 2025-07-24 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800726B1 (en) * 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
AR017831A1 (es) * 1997-12-10 2001-10-24 Pioneer Hi Bred Int Metodo para alterar la composicion de aminoacidos de una proteina nativa de interes, proteina elaborada, y polinucleotido
US20060159724A1 (en) * 2000-08-08 2006-07-20 Bell Stacey J Nutritional supplement for the management of weight
WO2003025153A2 (en) * 2001-09-17 2003-03-27 Monsanto Technology, Llc Enhanced proteins and methods for their use
US7273738B2 (en) * 2002-10-01 2007-09-25 Novozymes A/S Family GH-61 polypeptides
CN1557475A (zh) * 2004-02-04 2004-12-29 高春平 美容、减肥营养组合物
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis
WO2011082304A1 (en) * 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
EP2703484A4 (en) * 2011-03-24 2014-12-31 Asahi Glass Co Ltd TRANSFORMANT FROM YEAST OF ART SCHIZOSACCHAROMYCES, METHOD OF MANUFACTURING THEREOF, PROCESS FOR THE PREPARATION OF BETA-GLUCOSIDASE AND METHOD FOR THE DECOMPOSITION OF CELLULOSE
EP2831098A4 (en) * 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS

Similar Documents

Publication Publication Date Title
HK1206764A1 (en) Nutritive proteins and methods
HK1214739A1 (zh) 工程化的分泌蛋白质和方法
JP2015513904A5 (enExample)
HK1206370A1 (en) Charged nutritive proteins and methods
NZ628126A (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
JP2015501656A5 (enExample)
RU2019108268A (ru) Варианты химозина с улучшенными молокосвертывающими свойствами
IN2014CN00414A (enExample)
EA201190326A8 (ru) Полипептиды гормона роста и способы их получения и применения
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2015519878A5 (enExample)
MX2024010472A (es) Polipeptidos que enlazan adamts5, mmp13 y agrecano.
RU2014143031A (ru) Фрагменты питательных белков и способы их применения
MX2018016114A (es) Una novedosa fructosa-6-fosfato-3-epimerasa termoestable y un procedimiento para producir alulosa mediante el uso de la misma.
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
JP2015212284A5 (enExample)
MX2011008094A (es) Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
HK1206763A1 (en) Charged nutritive fragments, proteins and methods
JP2015518470A5 (enExample)
WO2010115995A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
JP2011125329A5 (enExample)
NZ612312A (en) Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
MX2019000082A (es) Una novedosa tagatosa-6-fosfato fosfatasa termoestable y un procedimiento para producir tagatosa usando la misma.
HK1206762A1 (en) Nutritive fragments and proteins with low or no phenylalanine and methods